Divisions of Pediatric Clinical Pharmacology and Allergy and Immunology, Department of Pediatrics, National Jewish Health, 1400 Jackson St, Rm J304, Molly Blank Building, Denver, CO 80206, USA.
J Allergy Clin Immunol. 2010 Jan;125(1):69-78. doi: 10.1016/j.jaci.2009.11.006.
This year's summary will focus on recent advances in pediatric asthma as reported in Journal of Allergy and Clinical Immunology publications in 2009. New National Asthma Education and Prevention Program asthma guidelines were released in 2007, with a particular emphasis on asthma control. Now that we have worked with the principals of the guidelines for 2 years, new insights are reported on how to implement the guidelines into clinical practice. This year's report will focus on gaps in management that need to be addressed, including health disparities, methods to improve asthma management through opportunities available in school-based asthma programs, and more information on the development of asthma in childhood. This information brings us closer to the point of managing children with controllable asthma and understanding reasons why asthma is not controlled in the remaining children. If we can close these gaps through better communication, improvements in the health care system, and new insights into treatment, we will move closer to better methods to intervene early in the course of the disease and induce clinical remission as quickly as possible in most children.
今年的总结将重点关注 2009 年《过敏与临床免疫学杂志》上发表的儿科哮喘的最新进展。新的《国家哮喘教育和预防计划》哮喘指南于 2007 年发布，特别强调了哮喘控制。现在我们已经按照指南的原则工作了 2 年，报告了如何将指南应用于临床实践的新见解。今年的报告将重点关注需要解决的管理差距，包括健康差距、通过学校哮喘计划提供的机会改善哮喘管理的方法，以及更多关于儿童哮喘发展的信息。这些信息使我们更接近于管理可控制哮喘的儿童，并了解为什么其余儿童的哮喘无法控制的原因。如果我们能够通过更好的沟通、改善医疗保健系统和对治疗的新见解来弥合这些差距，我们将更接近于找到更好的方法，以便在疾病早期进行干预，并尽快使大多数儿童获得临床缓解。
